Completed

The Effect of Myofascial Release in Patients With Subacromial Impingement Syndrome Randomized Controlled Trial

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Myofascial Release

Other
Who is being recruted

Shoulder Injuries+2

+ Joint Diseases

+ Musculoskeletal Diseases

From 20 to 60 Years
+5 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: January 2024
See protocol details

Summary

Principal SponsorTaif University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 11, 2024

Actual date on which the first participant was enrolled.

Shoulder pain, especially due to rotator cuff issues, is a common problem that affects many people, often limiting their ability to work, enjoy hobbies, or participate in sports. This study focuses on understanding how effective a technique called myofascial release is in helping people with rotator cuff tendinopathy, a condition where the tendons in the shoulder become irritated or damaged. Myofascial release is a hands-on therapy that involves applying gentle pressure to relieve tension in the connective tissues. This study aims to see if adding this technique to standard shoulder exercises and treatments can improve shoulder function and reduce pain, potentially offering a better quality of life for those affected by this condition. In this study, participants are divided into two groups. One group receives standard treatment, which includes exercises to strengthen shoulder muscles, improve range of motion, and ice application to reduce swelling. The other group receives the same treatment but with the addition of myofascial release therapy. Each participant attends two sessions per week for one month, with each session lasting between 30 to 45 minutes. Independent physical therapists assess all participants using various scales to measure pain, shoulder movement, and psychological distress, ensuring a thorough evaluation of the treatment's effectiveness. This study is designed to compare the outcomes of the two groups to determine the added benefit of myofascial release in managing shoulder pain.

Official TitleThe Effect of Myofascial Release in Patients With Subacromial Impingement Syndrome Randomized Controlled Trial
NCT06301490
Principal SponsorTaif University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

36 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 20 to 60 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Shoulder InjuriesJoint DiseasesMusculoskeletal DiseasesWounds and InjuriesShoulder Impingement Syndrome

Criteria

2 inclusion criteria required to participate
are aged between 20-60 years old,

have one or more than one positive finding in one of the following categories: (1) painful arc of movement during flexion or abduction; (2) Neer (sensitivity 0.78, specificity 0.58) or Kennedy-Hawkins (sensitivity 0.74, specificity 0.57) impingement signs[28]; and (3) pain during resisted external rotation, abduction or empty can test (sensitivity 0.69, specificity 0.62).[29] A combination of positive results to these clinical tests has values ≥ 0.74 for sensitivity and specificity for SIS.

3 exclusion criteria prevent from participating
have a history of glenohumeral luxation in the last 12 months or any fracture to the shoulder girdle.

have a shoulder pain reproduced by cervical movements. had a previous shoulder surgery, adhesive capsulitis, defined as loss of passive shoulder ROM greater than 50%, and

have a clinical sign of full-thickness tears of any rotator cuff muscles identified by lag signs [30]: drop sign (sensitivity 0.73, specificity 0.77), external rotation sign (sensitivity 0.46, specificity 0.94) and internal rotation sign (sensitivity 1.00, specificity 0.84).

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
18 participants will have strengthening exercises, rang of motion exercises and ice application for 10 mins, with adding Myofascial Release

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Taif University

Ta'if, Saudi ArabiaOpen Taif University in Google Maps
CompletedOne Study Center